David McMullen, MD, a neurological device regulator for the FDA, has been hired to lead medical affairs for Neuralink, a brain-computer interface startup founded by Elon Musk.
Dr. McMullen has served as director of the FDA’s Office of Neurological and Physical Medicine Devices since 2022, after nearly six years as National Institutes of Health program chief for neuromodulation and neurostimulation. He starts at Neuralink on Dec. 22.
“This role combines scientific rigor, direct patient impact, and the chance to move the entire field of BCI forward,” he said in a Dec. 9 news release. “My highest calling has always been to get safe and effective devices to the people who need them most. Neuralink is one of the very few places where that mission feels not just possible, but urgent.”
In 2025, Neuralink has continued to implant brain chips in paralyzed patients as part of a clinical trial, including at University of Miami Health System. The company also raised $650 million in June.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
